Chemomab Therapeutics (CMMB) Stock Chart & Stock Price History $3.14 -0.27 (-7.92%) Closing price 04:00 PM EasternExtended Trading$3.20 +0.06 (+2.07%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Chemomab Therapeutics Stock Price Performance The Chemomab Therapeutics (CMMB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 59.95%, with a year-to-date return of -56.63%. In the past month, the stock has decreased 27.98%, reflecting recent market activity. As of the latest close, Chemomab Therapeutics traded at $3.41 with a market cap of $16.06 million and volume of 463,101 shares. Receive CMMB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-11.80%1 Month Performance-27.98%3 Month Performance-42.39%Year-To-Date Performance-56.63%1 Year Performance-59.95% CMMB Stock Chart for Friday, August, 29, 2025 CMMB Chart by TradingView Chemomab Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/28/2025$3.48$3.41-2.01%$3.63$3.33463,101 shs$16.06 million08/27/2025$3.40$3.48+2.35%$3.78$3.35710,375 shs$65.63 million08/26/2025$3.48$3.40-2.29%$3.86$3.38120,237 shs$64.11 million08/25/2025$3.56$3.48-2.26%$3.70$3.3267,031 shs$16.41 million08/22/2025$3.54$3.56+0.56%$4.12$3.5375,603 shs$16.79 million08/21/2025$3.67$3.54-3.59%$3.73$3.5218,050 shs$16.69 million08/20/2025$3.72$3.67-1.29%$3.80$3.5619,961 shs$17.31 million08/19/2025$3.76$3.72-1.06%$3.80$3.7113,117 shs$17.54 million08/18/2025$3.72$3.76+1.08%$3.80$3.7622,529 shs$17.73 million08/15/2025$3.59$3.72+3.64%$3.80$3.6231,207 shs$17.54 million Get the Latest News and Ratings for CMMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/14/2025$3.83$3.59-6.34%$3.88$3.5646,694 shs$16.92 million08/13/2025$3.70$3.83+3.57%$3.87$3.7039,000 shs$18.07 million08/12/2025$3.80$3.70-2.63%$3.80$3.6422,387 shs$17.45 million08/11/2025$3.88$3.80-2.05%$3.92$3.6834,593 shs$17.91 million08/08/2025$3.88$3.88-0.01%$3.96$3.4945,330 shs$18.29 million08/07/2025$3.92$3.88-1.02%$4.04$3.8428,671 shs$18.29 million08/06/2025$3.88$3.92+1.03%$4.00$3.886,726 shs$18.48 million08/05/2025$4.00$3.88-3.00%$4.08$3.6430,613 shs$18.29 million08/04/2025$4.10$4.00-2.44%$4.20$3.9640,436 shs$18.86 million08/01/2025$4.28$4.10-4.21%$4.28$4.0826,555 shs$19.33 million07/31/2025$4.32$4.28-0.93%$4.50$4.2437,828 shs$20.18 million07/30/2025$4.36$4.32-0.92%$4.55$4.2415,795 shs$20.37 million07/29/2025$4.36$4.36$4.52$4.2518,452 shs$20.55 million07/28/2025$4.36$4.36$4.80$4.3636,654 shs$20.56 million Related Companies MGX Stock Chart ARTV Stock Chart ZIVO Stock Chart IVVD Stock Chart IRD Stock Chart RPTX Stock Chart INMB Stock Chart IMMX Stock Chart MNOV Stock Chart GANX Stock Chart Receive CMMB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CMMB) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemomab Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access